Darban H, Watson R R, Alak J, Thomas N
Department of Family and Community Medicine, NIAAA Specialized Alcohol Research Center, Tucson, AZ 85724.
Adv Exp Med Biol. 1993;335:143-51. doi: 10.1007/978-1-4615-2980-4_20.
As cocaine may affect progression of the Human Immunodeficiency Virus (HIV) infection to Acquired Immune Deficiency Syndrome (AIDS), we used a murine model of AIDS (MAIDS) induced by LP-BM5 murine leukemia virus to examine cocaine's possible role as a cofactor for secondary parasitic infections. Dissimilarities between the sexes were observed both in the absence and presence of the cocaine. The retrovirus-infected female mice had a much higher rate of Cryptosporidiosis than the retrovirus-infected male mice. Female, but not male, retrovirus-infected mice showed approximately 20-fold more Cryptosporidium per villus section than controls. Compared to respective gender controls, male and female animals infected with the retrovirus infection manifested a heightened Cryptosporidium oocysts count regardless of cocaine treatment. Overall, female groups incurred a higher incidence of infection compared to respective male groups. To determine the role of cocaine, groups of male and female C57BL-6 mice of similar age were treated with cocaine for 4 weeks followed by termination. Cocaine synergized with retrovirus infection in female mice to cause a 30-fold increase in the number of oocyst present. The spleen size and weight of female mice was significantly greater than uninfected controls or male mice. However, due to the very slow progression to murine AIDS in the males, parasite resistance was retained, including in cocaine treated C57BL-6 mice. Thymus cell number in the retrovirus-infected female mice decreased significantly in comparison to uninfected female controls. Continued resistance to the parasite in male mice and its loss in female mice was due to the rate of immunosuppression and thus development of retrovirus-induced murine AIDS.
由于可卡因可能会影响人类免疫缺陷病毒(HIV)感染向获得性免疫缺陷综合征(AIDS)的进展,我们使用了由LP - BM5鼠白血病病毒诱导的艾滋病小鼠模型(MAIDS)来研究可卡因作为继发性寄生虫感染辅助因子的可能作用。在有无可卡因的情况下均观察到了性别差异。感染逆转录病毒的雌性小鼠患隐孢子虫病的比率比感染逆转录病毒的雄性小鼠高得多。感染逆转录病毒的雌性小鼠(而非雄性小鼠)每绒毛节段的隐孢子虫数量比对照组多约20倍。与各自的性别对照组相比,感染逆转录病毒的雄性和雌性动物无论是否接受可卡因治疗,其隐孢子虫卵囊计数均有所增加。总体而言,雌性组的感染发生率高于各自的雄性组。为了确定可卡因的作用,将年龄相似的雄性和雌性C57BL - 6小鼠分组,用可卡因治疗4周后处死。可卡因与逆转录病毒感染协同作用,使雌性小鼠体内的卵囊数量增加了30倍。雌性小鼠的脾脏大小和重量明显大于未感染的对照组或雄性小鼠。然而,由于雄性小鼠向鼠艾滋病的进展非常缓慢,包括接受可卡因治疗的C57BL - 6小鼠在内,它们都保留了寄生虫抵抗力。与未感染的雌性对照组相比,感染逆转录病毒的雌性小鼠的胸腺细胞数量显著减少。雄性小鼠对寄生虫的持续抵抗力及其在雌性小鼠中的丧失是由于免疫抑制的速率以及逆转录病毒诱导的鼠艾滋病的发展。